Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic accuracy, operational feasibility, and cost considerations of Truenat MTB Plus and Xpert MTB/RIF Ultra for pulmonary tuberculosis.

PloS one·2026
Same author

Community empowerment in tuberculosis elimination.

The Indian journal of tuberculosis·2026
Same author

Ending TB by community empowerment: Challenges to access.

The Indian journal of tuberculosis·2026
Same author

Sustaining a national surgical educator workforce: a mixed-methods evaluation of faculty motivation and longitudinal retention in a urology simulation boot camp.

World journal of urology·2026
Same author

Artificial intelligence driven innovation in tuberculosis drug discovery.

The Indian journal of tuberculosis·2026
Same author

Corrigendum to "Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer": [Ann Oncol 36 (2025) 76-88].

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Related Experiment Video

Updated: May 24, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K

Tuberculosis and stigma: Break the silence….

V K Arora1, K K Chopra2, Sanjay Rajpal2

  • 1TB Association of India, 3 Red Cross Rd, Gokul Nagar, Sansad Marg Area, New Delhi, 110001, India.

The Indian Journal of Tuberculosis
|March 1, 2025
PubMed
Summary
This summary is machine-generated.

Social stigma surrounding diseases like tuberculosis (TB) and mental illness significantly hinders patient treatment adherence. Addressing these deep-rooted taboos is crucial for improving health outcomes and patient trust.

Keywords:
StigmaTuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Related Experiment Videos

Last Updated: May 24, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

Area of Science:

  • Medical Sociology
  • Public Health
  • Psychiatry

Background:

  • Social stigma, deeply rooted in cultural taboos, negatively impacts patient care and treatment adherence for various diseases.
  • Stigma erodes patient trust in healthcare providers, leading to decreased compliance with medical advice and follow-up care.

Discussion:

  • Patients may avoid or delay necessary treatment due to fear of social repercussions, exacerbating disease management challenges.
  • The impact of stigma is widespread, affecting not only infectious diseases like tuberculosis but also mental health conditions such as anxiety and depression.

Key Insights:

  • Stigma is a significant barrier to effective disease management, affecting approximately 40% of mental illness cases.
  • Reduced trust and poor treatment adherence are direct consequences of disease-related stigma.
  • Overcoming stigma is essential for improving patient outcomes and ensuring equitable healthcare access.

Outlook:

  • Future research should focus on developing and implementing culturally sensitive interventions to mitigate disease stigma.
  • Public health initiatives are needed to raise awareness and challenge social taboos associated with various illnesses.
  • Integrated care models addressing both the medical and psychosocial aspects of disease are vital for comprehensive patient support.